Lutetium-177 vipivotide tetraxetan in combination for treating PSMA-positive hormone-sensitive metastatic prostate cancer ID6589 Consultation on suggested remit, draft scope and provisional ...
Help us create the next version of Optuna! Optuna 5.0 Roadmap published for review. Please take a look at the planned improvements to Optuna, and share your feedback in the github issues. PR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results